Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy
Chimeric antigen receptor–engineered (CAR) T cells are emerging powerful therapies for patients with refractory/relapsed B-cell lymphomas. [<sup>18</sup>F]FDG PET/CT plays a key role during staging and response assessment in patients with lymphoma; however, the evidence about its utility...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/19/4700 |